Disease | leukemia |
Phenotype | C0011847|diabetes |
Sentences | 7 |
PubMedID- 25213141 | Acute myeloid leukemia with diabetes insipidus and hypophyseal infiltration. |
PubMedID- 22496152 | Increased incidence of non-hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. |
PubMedID- 25499068 | diabetes mellitus associated with leukemia (or = 9.23; 95% confidence interval 2.33-36.59); however, most instances occurred concurrent with or after the leukemia diagnosis. |
PubMedID- 24049363 | The clinical conditions and scores are as follows: 1 each: myocardial infarct, congestive heart failure, peripheral vascular disease, dementia, cerebrovascular disease, chronic lung disease, connective tissue disease, ulcer, chronic liver disease; 2 each: hemiplegia, moderate or severe kidney disease, diabetes, diabetes with complication, tumor, leukemia, lymphoma; 3 each: moderate or severe liver disease; and 6 each: malignant tumor, metastasis, aids. |
PubMedID- 20466781 | Context: the mechanism(s) by which imatinib improves glycemic control in chronic myeloid leukemia (cml) patients with type 2 diabetes remains unclear. |
PubMedID- 23037470 | Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitus. |
PubMedID- 24286261 | Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature. |
Page: 1